A large propensity-matched study linked outpatient melatonin use to a small reduction in REM sleep in children evaluated for polysomnography.
|Articles|December 1, 1996
Supplements and Featured Publications
- Creating an Optimal Strategy for Lipid Management
- Volume 2
- Issue 11 Suppl
Recent Clinical Trials and Aggressive Management of Dyslipidemic Patients
Author(s)Donald B. Hunninghake, MD
Advertisement
Articles in this issue
almost 30 years ago
Dialogue: Implementation of Guidelines in a Managed Care Settingalmost 30 years ago
Dialogue: The Lipid-Lowering Formularyalmost 30 years ago
Case Study Balmost 30 years ago
Case Study Calmost 30 years ago
Case Study Dalmost 30 years ago
Goals and Objectivesalmost 30 years ago
Introduction: Creating an Optimal Strategy for Lipid Managementalmost 30 years ago
Epidemiologic Studies of Diet and Drug Therapy to Reach Target LDL-C Levelsalmost 30 years ago
Implementation of Guidelines in a Managed Care Settingalmost 30 years ago
The Lipid-Lowering FormularyAdvertisement
Related to this article
Prior authorization and compounded drugs remain top obesity care access barriers, says NYU Langone's Holly Lofton, MD.
Panelists say IRA, Most Favored Nation rules and fragmented data are freezing value-based deals for durable one-time therapies.
Payers say NCCN guideline concordance sets a baseline for cancer coverage, but cost and formulary variation may still limit access.
FDA approved belzutifan plus lenvatinib for advanced ccRCC after PD-1/PD-L1 therapy, expanding treatment options for those with disease progression.
A 3-year registry found dupilumab controlled atopic dermatitis (AD) in most children, though those under 6 years were likelier to stop treatment.
Machine learning identified age, BMI, income, and reproductive factors as key predictors of overactive bladder risk among US women.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
Advertisement
Trending on AJMC
1
Surrogate End Points, Drug Costs Complicate Oncology Formularies
2
COVID-19 or Flu? Symptoms Alone Can't Tell: Tammy Lundstrom, MD, JD
3
Perceptions About CGMs Among Primary Care Physicians and Endocrinologists
4
Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges
5